Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis
Clinical trial NCT00134563 · COMPLETED
Trial details
- NCT number
- NCT00134563
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2010-07-01
- Enrollment
- 1088
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.